Amicus Therapeutics, Inc.FOLDNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+117.5%
5Y CAGR+70.3%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
+117.5%/yr
Annual compound
5Y CAGR
+70.3%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
14.3x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 179.72% |
| 2024 | 51.07% |
| 2023 | 55.07% |
| 2022 | 17.46% |
| 2021 | 12.74% |
| 2020 | 12.54% |
| 2019 | 11.70% |
| 2018 | -39.20% |
| 2017 | -40.60% |
| 2016 | -49.10% |